Canine Science

Von Willebrand Disease in Dogs: Genetics, Symptoms & Management Guide

Learn about vWD in dogs — the science behind this inherited bleeding disorder, breed risks, symptoms, diagnosis, and how to manage von Willebrand disease in your dog.

By Anouk Beaumont · Published 9 July 2026

Von Willebrand Disease in Dogs: Genetics, Symptoms & Management Guide

What Is Von Willebrand Disease (vWD) in Dogs?

Von Willebrand disease (vWD) is the most common inherited bleeding disorder in dogs. It results from a deficiency or dysfunction of von Willebrand factor (vWF), a protein essential for platelet adhesion during blood clotting. Dogs with vWD may experience prolonged bleeding after injury, surgery, or even spontaneously. While vWD is manageable, there is no cure — and it can be life-threatening in severe cases. If you suspect your dog has a bleeding disorder, consult your veterinarian immediately for proper diagnostic testing.

The Science Behind vWD in Dogs

Physiological Mechanism: How vWF Works

Von Willebrand factor is a large multimeric glycoprotein produced primarily by endothelial cells lining blood vessel walls and, to a lesser extent, by megakaryocytes (platelet precursor cells). In a healthy dog, vWF serves two critical functions in hemostasis:

Platelet adhesion: When a blood vessel is damaged, vWF binds to exposed collagen in the subendothelial matrix and to glycoprotein Ib receptors on platelet surfaces, essentially acting as molecular "glue" that tethers platelets to the injury site.
Factor VIII stabilization: vWF circulates bound to coagulation Factor VIII, protecting it from premature degradation. Without sufficient vWF, Factor VIII levels can also drop, compounding clotting deficits.

When vWF is deficient or structurally abnormal, platelets cannot adhere effectively to damaged vessel walls. The result is a primary hemostatic defect — bleeding from mucosal surfaces, prolonged oozing from wounds, and in severe cases, spontaneous hemorrhage into joints or body cavities.

According to the Merck Veterinary Manual, vWD is classified into three types based on the nature of the vWF deficiency:

Type	Mechanism	Severity	Inheritance
Type I	Reduced vWF concentration; structurally normal protein	Mild to moderate	Autosomal recessive (most common)
Type II	Normal vWF concentration but structurally abnormal multimers	Moderate to severe	Autosomal recessive
Type III	Complete or near-complete absence of vWF	Severe, potentially fatal	Autosomal recessive

Type I vWD accounts for approximately 70–80% of all canine cases and is the most frequently diagnosed form in breeds like Doberman Pinschers, where prevalence estimates suggest 25–30% of the breed carries at least one copy of the causative mutation. Type III, the most dangerous form, is rare but documented in Scottish Terriers, Shetland Sheepdogs, and Chesapeake Bay Retrievers.

Evolutionary Context: Why vWD Persists in the Canine Gene Pool

Ancestral Origins and Selective Pressure

Von Willebrand factor is an ancient protein found across all jawed vertebrates — its role in hemostasis is so fundamental that it has been conserved for over 400 million years of vertebrate evolution. In wild canids (wolves, coyotes, foxes), severe vWF deficiencies would likely be rapidly selected against: a wolf that bleeds excessively from a minor wound or fails to clot after a hunting injury would face immediate survival disadvantage.

However, the persistence of vWD-causing mutations in domestic dogs is largely a consequence of artificial selection and breed formation. When dog breeds were established — often from small founder populations in the 19th and early 20th centuries — genetic bottlenecks concentrated rare recessive alleles. The Doberman Pinscher breed, developed in Germany in the 1890s by Karl Friedrich Louis Dobermann from a limited number of foundation dogs, is a textbook example. The vWF mutation present in one or more founding animals was propagated through generations of selective breeding for temperament and appearance, not hemostatic function.

This is a classic case of founder effect combined with genetic drift — evolutionary forces that operate powerfully in small, closed populations. Modern breed registries that require closed studbooks inadvertently perpetuate these inherited disorders by limiting the gene pool available for correction.

Breed Variations: Which Dogs Are Most at Risk?

Over 50 dog breeds have documented cases of vWD, but prevalence varies dramatically. Research published in the Journal of Veterinary Internal Medicine and data compiled by veterinary genetic testing laboratories have identified the following breeds as having the highest documented risk:

Breed	Most Common vWD Type	Estimated Carrier/Affected Rate	Known Genetic Mutation
Doberman Pinscher	Type I	~25–30% affected; ~15–20% carriers	Yes (vWF gene splice-site mutation)
Scottish Terrier	Type III	~2–4% affected	Yes (deletion mutation)
Shetland Sheepdog	Type III	~1–3% affected	Yes
German Shorthaired Pointer	Type II	~10–15% carriers	Yes
Welsh Corgi (Pembroke)	Type I	~5–10% carriers	Yes
Chesapeake Bay Retriever	Type III	Rare but documented	Yes
Manchester Terrier	Type I	~5% carriers	Yes
French Bulldog	Type I	Emerging concern; rates under study	Under investigation

It is critical to understand that mixed-breed dogs are not immune to vWD. While hybrid vigor (heterozygosity) reduces the probability of inheriting two copies of a recessive mutation, any dog with an affected breed in its ancestry can carry or express the disorder. DNA testing through laboratories like AKC-approved genetic testing providers is available for most known vWF mutations and typically costs $65–$150 per test.

Symptoms and Diagnosis: What to Watch For

Clinical Signs of vWD in Dogs

Unlike hemophilia (Factor VIII or IX deficiency), which tends to produce deep tissue and joint bleeding, vWD primarily causes mucosal and surface bleeding. Symptoms can range from subtle to dramatic depending on the type and severity:

Mild to Moderate Signs (Type I)

Prolonged bleeding after nail trims (more than 5–10 minutes)
Frequent nosebleeds (epistaxis)
Bleeding gums, especially during teething or after chewing hard toys
Prolonged bleeding after minor cuts or scratches
Easy bruising on the abdomen or inner thighs
Blood in urine (hematuria) or stool (melena)
Excessive bleeding during estrus (heat cycles) in intact females

Severe Signs (Type II/III)

Spontaneous hemorrhage without apparent injury
Uncontrolled bleeding after routine procedures (spay/neuter, dental extraction)
Hemorrhage into joints (hemarthrosis) causing lameness
Gastrointestinal bleeding causing anemia, weakness, pale gums
Hemothorax (blood in chest cavity) — life-threatening emergency
Neonatal mortality from umbilical cord bleeding

Many Type I vWD dogs are asymptomatic or only mildly symptomatic throughout life, with the disorder discovered incidentally during pre-surgical bloodwork. This is one reason why pre-anesthetic coagulation screening is considered best practice for all dogs undergoing elective surgery.

Diagnostic Tests Your Veterinarian Will Run

If your vet suspects vWD, expect the following diagnostic workup:

Test	What It Measures	Typical Cost Range	Turnaround Time
Buccal Mucosal Bleeding Time (BMBT)	Functional platelet-vessel wall interaction	$50–$120	Immediate (in-clinic)
vWF Antigen Assay (vWF:Ag)	Quantitative vWF protein concentration in plasma	$80–$200	5–10 business days (reference lab)
DNA (Genetic) Test	Presence of known breed-specific vWF mutation	$65–$150	2–4 weeks
Complete Blood Count (CBC)	Platelet count, anemia assessment	$50–$100	Same day
Coagulation Panel (PT/aPTT)	Rules out other clotting disorders (e.g., rodenticide toxicity, hemophilia)	$80–$180	1–3 days

The vWF:Ag assay remains the gold standard for phenotypic diagnosis. Results are reported as a percentage of normal canine pooled plasma:

>50%: Normal
30–50%: Borderline / equivocal
<30%: Consistent with vWD (likely carrier or mildly affected)
<10%: Severely affected (Type II or III)

Practical Takeaways for Owners

Diagnostic testing costs for a complete vWD workup typically range from $300–$750 depending on your veterinary clinic's location and whether samples are sent to a specialty reference laboratory such as Cornell's Animal Health Diagnostic Center or Auburn's Hemostasis Laboratory. Pet insurance policies vary in coverage for inherited condition diagnostics — check whether your plan includes hereditary/congenital condition coverage before testing.

Treatment and Daily Management of vWD Dogs

There is currently no cure for von Willebrand disease in dogs. Management focuses on preventing bleeding episodes, treating acute hemorrhage, and minimizing risk during necessary medical procedures.

Medical Treatments

Desmopressin acetate (DDAVP): This synthetic analog of vasopressin stimulates the release of stored vWF from endothelial cells. It is administered subcutaneously (typically 1 mcg/kg) approximately 30–60 minutes before a planned surgical procedure. DDAVP is most effective in Type I vWD, where functional vWF exists in storage but at reduced circulating levels. Cost: approximately $15–$40 per dose. Note: DDAVP has limited to no efficacy in Type III vWD, where vWF stores are absent.

Cryoprecipitate transfusion: For severe bleeding episodes or Type II/III patients requiring surgery, cryoprecipitate (a concentrated plasma fraction rich in vWF and Factor VIII) is the treatment of choice. A single unit costs approximately $80–$200, and multiple units may be required depending on the dog's size and severity of hemorrhage. Fresh frozen plasma (FFP) is a second-line option when cryoprecipitate is unavailable, though it is less concentrated and requires larger volumes.

Tranexamic acid: This antifibrinolytic medication helps stabilize formed clots by inhibiting plasminogen activation. It is sometimes used as an adjunct therapy during bleeding episodes. Typical dosing is 10–25 mg/kg IV or orally every 8 hours. Your veterinarian will determine the appropriate protocol.

Daily Life Adjustments

Owning a dog with confirmed vWD requires specific lifestyle modifications:

Avoid high-impact activities that risk trauma: rough wrestling with other dogs, jumping from heights, or activities with high collision risk (e.g., flyball for severely affected dogs).
Use soft-bristle toothbrushes or enzymatic dental gels rather than hard dental chews that can cause gingival bleeding.
Keep styptic powder (e.g., Kwik Stop) on hand for nail trim accidents. Apply firm pressure for 2–3 minutes to any bleeding nail.
Inform every veterinary provider who treats your dog about the vWD diagnosis — including emergency clinics and specialists. Consider a medical alert tag on your dog's collar.
Never administer NSAIDs (ibuprofen, aspirin, carprofen, meloxicam) without explicit veterinary approval — these drugs inhibit platelet function and can precipitate dangerous bleeding in vWD dogs.
Discuss pre-surgical DDAVP protocols with your vet well in advance of any planned procedure, including routine dental cleanings.
Keep a pet first-aid kit stocked with gauze, elastic bandages, and your vet's emergency number. For severe bleeds, apply direct pressure and transport to the nearest emergency veterinary hospital immediately.

Cost of Long-Term Management

Annual management costs for a mildly affected Type I vWD dog may be as low as $100–$300 (periodic monitoring, styptic supplies, pre-surgical DDAVP). For a severely affected Type III dog, annual costs can range from $1,500–$5,000+ due to transfusion needs, emergency visits, and specialized care. Pet insurance premiums for dogs with pre-existing vWD diagnoses will typically exclude the condition, making early testing before symptom onset financially strategic.

Common Misconceptions About vWD in Dogs

Myth	Fact
"Only Dobermans get vWD."	While Dobermans have the highest documented prevalence, vWD has been identified in over 50 breeds and mixed-breed dogs. Scottish Terriers and Shelties are at particular risk for the severe Type III form.
"If my dog has never bled abnormally, they don't have vWD."	Many Type I vWD dogs are clinically silent until a major hemostatic challenge — surgery, trauma, or concurrent illness — unmasks the deficiency. Pre-surgical screening exists for this exact reason.
"vWD is the same as hemophilia."	Hemophilia (Factor VIII or IX deficiency) is a secondary hemostatic disorder affecting the coagulation cascade. vWD is a primary hemostatic disorder affecting platelet adhesion. The bleeding patterns, diagnostic tests, and treatments differ significantly.
"A normal platelet count rules out vWD."	Platelet counts are typically normal in vWD. The problem is not platelet number but platelet function — specifically, the inability of platelets to adhere to damaged vessel walls without adequate vWF. A CBC alone will not detect vWD.
"vWD dogs have short lifespans."	With proper management, most Type I vWD dogs live full, normal lifespans. Even Type III dogs can have good quality of life with proactive veterinary care and owner vigilance.

How Is vWD in Dogs Different From vWD in Humans?

Von Willebrand disease affects humans too — it is the most common inherited bleeding disorder in people, with an estimated prevalence of 1% globally. While the underlying mechanism is the same (deficient or dysfunctional vWF), there are notable differences:

Inheritance patterns: Human Type I vWD is often inherited in an autosomal dominant pattern with incomplete penetrance, meaning a single copy of the mutation can produce symptoms. In most dog breeds, vWD is autosomal recessive, requiring two copies for full expression (though carriers with one copy may show mildly reduced vWF levels).
Type distribution: Type I dominates in both species, but Type III vWD is exceedingly rare in humans (prevalence ~0.5–1 per million) while being overrepresented in certain dog breeds like Scottish Terriers.
Treatment options: Human patients have access to recombinant vWF concentrates (e.g., vonvendi®) approved by the FDA. No equivalent recombinant product is currently approved for veterinary use in dogs — treatment relies on plasma-derived products and DDAVP.
Diagnostic standardization: Human vWD diagnosis benefits from highly standardized multimer analysis and ristocetin cofactor assays. Canine testing, while reliable, has fewer standardized reference ranges across breeds, which is why breed-specific baselines are important.

When vWD-Like Bleeding Might Signal Something Else

Not all abnormal bleeding in dogs is caused by vWD. Several other conditions can produce similar symptoms and must be ruled out through proper veterinary diagnostics:

Rodenticide (rat poison) toxicity: Anticoagulant rodenticides (warfarin, brodifacoum) inhibit vitamin K-dependent clotting factors. This is a medical emergency — if you suspect your dog has ingested rodenticide, contact the ASPCA Animal Poison Control at (888) 426-4435 (24/7, consultation fee applies) or go to the nearest emergency vet immediately.
Thrombocytopenia: Low platelet counts from immune-mediated disease (IMTP), tick-borne illnesses (Ehrlichia, Anaplasma), or bone marrow disorders can cause mucosal bleeding indistinguishable from vWD on casual observation.
Liver disease: The liver produces most coagulation factors. Severe hepatic dysfunction (cirrhosis, portosystemic shunts, acute liver failure) causes bleeding tendencies through factor deficiency rather than vWF problems.
Hemophilia A and B: Factor VIII and IX deficiencies produce deep tissue bleeding and joint hemorrhage more commonly than mucosal bleeding — a different clinical pattern, but one that requires similar diagnostic workup to distinguish.
Ehlers-Danlos syndrome: This connective tissue disorder causes fragile skin and blood vessels, leading to easy bruising and bleeding that can mimic vWD.

When to See the Vet Immediately

Seek emergency veterinary care if your dog exhibits any of the following:

Bleeding that does not stop after 10 minutes of direct pressure
Sudden weakness, collapse, or pale/white gums (signs of internal hemorrhage)
Blood in vomit, urine, or stool (especially dark, tarry stool)
Unexplained swelling of joints or limbs
Difficulty breathing (possible hemothorax)
Known vWD dog with any uncontrolled bleeding episode

Frequently Asked Questions About vWD in Dogs

Can dogs with vWD live a normal life?

Yes. Most dogs with Type I vWD — the most common form — live normal lifespans with minimal lifestyle adjustments. Type II and III dogs require more intensive management but can still have excellent quality of life with a knowledgeable owner and a proactive veterinary team. The key is early diagnosis, avoiding unnecessary trauma, and having a plan in place for surgical procedures and emergencies.

Is vWD in dogs curable?

No. vWD is a genetic disorder caused by mutations in the vWF gene, and there is currently no gene therapy or cure available for canine vWD. Treatment is supportive and preventive. Research into gene therapy for inherited canine disorders is ongoing at institutions like the University of Pennsylvania's School of Veterinary Medicine, but clinical applications for vWD specifically are not yet available.

Should I breed a dog that carries the vWD mutation?

Responsible breeding practices strongly discourage breeding dogs that are affected by vWD (homozygous for the mutation). Carrier dogs (heterozygous, one copy) can be bred to genetically clear mates without producing affected puppies — but all offspring should be DNA tested before any future breeding decisions. The AKC and breed-specific health foundations recommend DNA testing for vWF mutations as part of pre-breeding health screening for at-risk breeds.

How much does vWD genetic testing cost?

DNA-based vWD testing typically costs between $65 and $150 per test through laboratories such as Paw Print Genetics, Embark, or university-affiliated labs. Some comprehensive breed health panels that include vWF mutation screening alongside other breed-relevant tests (e.g., degenerative myelopathy, exercise-induced collapse) range from $150–$350. Testing is performed on a cheek swab or blood sample.

Can vWD be detected in puppies?

DNA testing can be performed on puppies as young as 6–8 weeks of age using cheek swab samples. Phenotypic testing (vWF:Ag assay) is less reliable in very young puppies because vWF levels can fluctuate during growth and development — retesting at 12–16 months is recommended for definitive phenotypic classification. If you are purchasing a puppy from a breed at risk for vWD, ask the breeder for documented DNA test results for both parents.

What does it mean when my dog bleeds excessively from minor wounds?

Prolonged bleeding from minor cuts, nail trims, or dental procedures is the hallmark clinical sign of a primary hemostatic disorder — vWD being the most common. However, it can also indicate thrombocytopenia, platelet function defects, or medication side effects. If your dog consistently takes more than 5–10 minutes to stop bleeding from a minor wound, schedule a veterinary appointment for a coagulation workup.

Is vWD in dogs hereditary?

Yes. vWD is an inherited genetic disorder passed from parent dogs to offspring through mutations in the von Willebrand factor gene. In most breeds, the inheritance pattern is autosomal recessive — meaning a dog must inherit two copies of the mutation (one from each parent) to be fully affected. Dogs inheriting one copy are carriers and may have mildly reduced vWF levels without clinical symptoms.